-
psnet.ahrq.gov/perspective/identifying-safety-events-prehospital-setting
May 16, 2022 - they can prepare on their end, the things that need to be done for that or, if I have a patient with severe
-
effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
March 01, 2010 - stakeholders; rather, hospitalizations would be a better final health marker since this indicates more severe
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2020_Core_Weighted_V2.PDF
January 01, 2020 - 869: OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC 2,695 0.01%
870: SEPTICEMIA OR SEVERE … SEPSIS WITH MV >96 HOURS 134,140 0.41%
871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC … 1,482,790 4.58%
872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC 420,685 1.30%
876
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2022_Core_Weighted.PDF
January 01, 2022 - 869: OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC 2,720 0.01%
870: SEPTICEMIA OR SEVERE … SEPSIS WITH MV >96 HOURS 96,850 0.29%
871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC … 1,523,805 4.63%
872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC 427,200 1.30%
876
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2021_Core_Weighted.PDF
January 01, 2021 - 869: OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC 3,035 0.01%
870: SEPTICEMIA OR SEVERE … SEPSIS WITH MV >96 HOURS 131,490 0.39%
871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC … 1,506,958 4.52%
872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC 427,014 1.28%
876
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2014chartbooks/womenhealth/2014nhqdr-womenhealth.pptx
January 01, 2020 - Events treated in ambulatory settings may be less severe than those occurring in inpatient settings. … prevent the need for hospitalization or for which early intervention can prevent complications or more severe … prevent the need for hospitalization or for which early intervention can prevent complications or more severe
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2017_Core_Weighted.PDF
January 01, 2017 - 0.02%
869: OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC 4,389 0.01%
870: SEPTICEMIA OR SEVERE … SEPSIS W MV >96 HOURS 66,943 0.19%
871: SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W MCC 1,217,202 … 3.40%
872: SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W/O MCC 484,335 1.35%
876: O.R.
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2021_Core_Weighted.PDF
January 01, 2021 - 869: OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC 2,729 0.01%
870: SEPTICEMIA OR SEVERE … SEPSIS WITH MV >96 HOURS 125,575 0.38%
871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC … 1,501,735 4.49%
872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC 440,144 1.32%
876
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2016_Core_Weighted.PDF
January 01, 2016 - 0.02%
869: OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC 4,965 0.01%
870: SEPTICEMIA OR SEVERE … SEPSIS W MV >96 HOURS 64,821 0.18%
871: SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W MCC 1,085,956 … 3.05%
872: SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W/O MCC 452,762 1.27%
876: O.R.
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2016_MaskedStats_Core_Weighted.PDF
January 01, 2016 - 0.02%
869: OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC 1,864 0.03%
870: SEPTICEMIA OR SEVERE … SEPSIS W MV >96 HOURS 1,632 0.03%
871: SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W MCC 14,537 0.23% … 872: SEPTICEMIA OR SEVERE SEPSIS W/O MV >96 HOURS W/O MCC 15,592 0.25%
876: O.R.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/machine-learning-quality_research.pdf
September 01, 2012 - Most patients had severe dementia.
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
January 01, 2024 - Implementation Guide: Prediabetes and Type 2 Diabetes: Part Two, Counseling
Implementation Guide
Prediabetes and Type 2 Diabetes:
Part Two, Counseling
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
Contract No. 75FCMC18D0047
Prepared by:
CMS Alliance to Mode…
-
digital.ahrq.gov/sites/default/files/docs/publication/uc1hs015196-crandall-final-report-2007.pdf
January 01, 2007 - Rural Iowa Redesign of Care Delivery with EHR Functions - Grant Final Report Grant ID: 1UC1HS015196-0.
1
Grant Final Report
Grant ID: 1UC1HS015196-0
Rural Iowa Redesign of Care Delivery with
EHR Functions
Inclusive Dates: 09/01/04 – 11/30/07
Principal Investigator:
Donald K Cranda…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
December 01, 2017 - Management of Uterine Fibroids - Evidence Summary
Comparative Effectiveness Review
Number 195
Effective Health Care Program
Management of Uterine Fibroids
Evidence Summary
Introduction
Uterine fibroids (i.e., leiomyomata) are
common benign smooth muscle tumors
of the uterus. Most women will develop
one or mor…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-health-children_disposition-comments.pdf
December 19, 2016 - Disposition of Comments for CER 181 Mental Health Care
Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/
?pageaction=displayproduct&productid=2372
Published Online: December 19, 2016
Comparative Effectiveness Review Disposition of Comments Report
Research Revie…
-
www.ahrq.gov/sites/default/files/publications2/files/dx-safety-21-diagnostic-stewardship.pdf
August 01, 2024 - Diagnostic Safety Issue Brief 21 Diagnostic Stewardship as a Model To Improve the Quality and Safety of Diagnosis
Issue Brief 21
Diagnostic Stewardship as a Model
To Improve the Quality and Safety
of Diagnosis
PATIENT
SAFETY
e
This page intentionally left blank.
e
Issue Brief 21
Diagnostic Stewardshi…
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/news-and-events/events/webinars/cahps-moving-forward-webcast.pdf
October 01, 2017 - CAHPS Moving Forward: Innovations in Tools and Research
CAHPS® Moving Forward: Innovations in Tools and Research
October 2017 Webcast
Speakers
Caren Ginsberg, PhD, Director, CAHPS Division, Center for Quality Improvement and Patient Safety, Agency
for Healthcare Research and Quality
Ron Hays, PhD, Adjunct Res…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/VN82XmdDhcK74WtHxWBTqm
May 01, 2004 - ahrq37a_LungCancer_Sum.qxd
Screening for lung cancer is not currently
recommended by any major medical professional
organization. The U.S. Preventive Services Task
Force (USPSTF) gave lung cancer screening a “D”
recommendation in both 1985 and 1996, meaning
that there were fair-quality data to recommend
against scree…
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/news-and-events/events/20140115_DB/Final_Using_the_CAHPS_Database_Webcast_Transcript.pdf
January 01, 2014 - Using the CAHPS Database to Compare, Report, and Improve Organizational Performance
Using the CAHPS Database to Compare, Report, and Improve Organizational
Performance
January 2014 Webcast
Speakers
Janice Ricketts, Senior Study Director, CAHPS Database, Westat, Rockville, MD
Deborah Kilstein, BSN, MBA, Vice…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/evidence-based-reports/nutrtp4.pdf
February 01, 2012 - Nutritional Research Series - Volume 4: Effects of Eicosapentanoic Acid and Docosahexanoic Acid on Mortality Across Diverse Settings: Systematic Review and Meta-Analysis of Randomized Trials and Prospective Cohorts
Technical Review 17
Nutritional Research Series
Volume 4: Effects of Eicosapentanoic Aci…